Figshareopen access
<i>CIS Predicts PFS in mccRCC</i>
nephrology and urology, composite inflammatory score, metastatic clear cell renal cell carcinoma, toripalimab, axitinib, progression-free survival, lasso, nomogram
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 264753
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.